- Open Access
Inhalation of rod-like carbon nanotubes causes unconventional allergic airway inflammation
© Rydman et al.; licensee BioMed Central Ltd. 2014
Received: 17 April 2014
Accepted: 27 August 2014
Published: 16 October 2014
Carbon nanotubes (CNT) represent a great promise for technological and industrial development but serious concerns on their health effects have also emerged. Rod-shaped CNT are, in fact, able to induce asbestos-like pathogenicity in mice including granuloma formation in abdominal cavity and sub-pleural fibrosis. Exposure to CNT, especially in the occupational context, happens mainly by inhalation. However, little is known about the possible effects of CNT on pulmonary allergic diseases, such as asthma.
We exposed mice by inhalation to two types of multi-walled CNT, rigid rod-like and flexible tangled CNT, for four hours a day once or on four consecutive days. Early events were monitored immediately and 24 hours after the single inhalation exposure and the four day exposure mimicked an occupational work week. Mast cell deficient mice were used to evaluate the role of mast cells in the occurring inflammation.
Here we show that even a short-term inhalation of the rod-like CNT induces novel innate immunity-mediated allergic-like airway inflammation in healthy mice. Marked eosinophilia was accompanied by mucus hypersecretion, AHR and the expression of Th2-type cytokines. Exploration of the early events by transcriptomics analysis reveals that a single 4-h exposure to rod-shaped CNT, but not to tangled CNT, causes a radical up-regulation of genes involved in innate immunity and cytokine/chemokine pathways. Mast cells were found to partially regulate the inflammation caused by rod-like CNT, but also alveaolar macrophages play an important role in the early stages.
These observations emphasize the diverse abilities of CNT to impact the immune system, and they should be taken into account for hazard assessment.
Allergic asthma is a chronic inflammatory disorder of the epithelial surfaces of the lung, characterized by airway hyperresponsiveness (AHR), mucus overproduction, pulmonary eosinophilia and allergen-driven T helper (Th) 2 lymphocyte polarization . Coordinated production of the Th2 cytokines IL-4, IL-5 and IL-13, and production of allergen-specific IgE antibodies drives the allergic inflammation through the recruitment and activation of T-cells and eosinophils. Chronic Th2 inflammation may finally lead to structural changes in the airways in a process called airway remodeling . Despite the involvement of several cell types, Th2 cells are considered to be pivotal in the pathobiology of asthma.
Asthma represents the most important chronic inflammatory disease of the lung and is the major childhood illnesses in Europe and in US. The incidence of asthma is steadily increasing in industrialized countries affecting about 5–10% of the population ,. The reason of increased asthma prevalence is unknown but it has been linked with improved hygienic standards. This has been called the “hygiene hypothesis” arguing that early childhood exposure to microbes inhibits the tendency to develop allergic diseases . On the other hand, a competing hypothesis suggests that more exposure to a wide variety of novel chemicals in the environment, in consumer products and in occupational settings, is the major cause for the sudden peak in asthma prevalence ,.
The unique properties of carbon nanomaterials and their applications have the potential for a remarkable technological and economic growth . The ability to custom synthesize carbon nanotubes (CNT) with attached functional groups has opened new avenues to design high surface area catalyst supports and materials with high photochemical and electrochemical activity . CNT are also among the strongest and stiffest materials yet discovered in terms of tensile strength and elastic modulus. However, the rod-like shape of certain types of CNT has been compared to asbestos fibers, raising concern that their widespread use may lead to serious health consequences. It has been previously reported that rigid rod-like CNT are able to induce asbestos like pathogenicity when introduced as a single intraperitoneal dose to mice, acting as a surrogate tissue for mesothelial lining of the lung . Moreover, subcutaneous , intratracheal  and intranasal  administration of multi-walled CNT have been shown to aggravate allergen-induced airway inflammation and inhalation of high-dose of the CNT has been found to reach the sub-pleural tissue and induce sub-pleural fibrosis in OVA-sensitized mice . In the present study, we examined whether inhalation exposure, mimicking real-life exposure scenarios, to rigid rod-shaped CNT (rCNT) or to tangled CNT (tCNT) without pre-sensitization to any allergens is able to induce asthma-like pathologies.
Inhaled rCNT trigger eosinophilia in lungs
Inhalation of rCNT induces signs associated with allergic airway inflammation
Mast cells partially regulate the development of rCNT-triggered allergic-like airway inflammation
Transcriptome analysis of lung tissue reveals rapid activation of innate immune system in response to inhaled rCNT
Alveolar macrophages and mast cells play a role in the initiation of the inflammatory and allergy-like rCNT-induced responses
The role of mast cells was investigated in lung tissue of C57BL/6 and KitW-sh mice exposed to rCNT for 4 h and sacrificed on the following day. Results of mRNA expression levels of Th2 type cytokines and pro-allergic chemokines showed that Il-13 and Il-4 were derived from mast cells (Figure 5c) while expression of Il-33, Il-5, Ccl11, Ccl24 and Ccl17 was not influenced by deficiency of these cells (Additional file 8).
Along with the increase in production and use of CNT in numerous applications, also occupational and environmental exposure to these materials has increased. This has raised awareness of the potential harmfulness of CNT on human health. One of the main exposure routes associated with ENM is the respiratory tract and hence most of the in vivo studies have concentrated on investigating pulmonary effects.
Several studies have shown that CNT fibers have adjuvant capacity as they aggravate allergen-induced airway inflammation -,,. Here, we investigated whether CNT have the ability to induce characteristics similar to allergic airway inflammation in healthy mice. Using different types of CNT, we exposed C57BL/6 mice to an aerosol of rCNT or tCNT repeatedly for 4 h, for a total of 4 days and collected samples 24 h after the last treatment, thus mimicking a one-week occupational exposure. Inhalation of rCNT elicited a drastic infiltration of eosinophils but only a minor increase in neutrophils. Pulmonary eosinophilia is a classical sign of allergic airway inflammation and asthma in which eosinophils are critically involved in the induction of airway hyperreactivity, elevated mucus production, airway remodeling and asthma exacerbations ,. In contrast, exposure to tCNT did not cause morphologically evident lung inflammation. In a study by Park et al. neutrophilic inflammation was induced one day after intratracheal administration of multi-walled carbon nanotubes (MWCNT) . Similarly, Morimoto et al. reported MWCNT-induced neutrophilia peaking at day 3 after intratracheal instillation . However, other studies performed via pharyngeal aspiration have shown that MWCNT induce an influx of both neutrophils and eosinophils,  especially at lower doses . Although the inhalation method is the closest to real-life scenarios, the number of such studies is very limited. In contrast to our observations, a 3-month inhalation of MWCNT induced mild neutrophilic, but not eosinophilic, pulmonary inflammation in rats . Similar phenomenon was seen also in mice where the authors reported pulmonary neutrophilia after a 2-day exposure . Nonetheless, assessing health effects of CNT in vivo is complex and different results difficult to compare, due to varying methods of exposure in different organisms as well as the different physico-chemical properties of the tested materials.
In the present study, the rCNT triggered cytopathology included a substantial number of macrophages that attempted to engulf CNT aggregates and a presence of foreign body giant cells (FBGC). However, the FBGC did not appear in mice after tCNT treatment. Macrophages undergoing “frustrated phagocytosis” and formation of FBGC in response to MWCNT have been reported earlier after intraperitoneal injection using the same material as in our study . Mangum et al. found carbon bridges between macrophages after a single oropharyngeal aspiration of SWCNT in rats. Giant cells arise from a fusion of macrophages in response to large foreign material . These cells are recognized as the pathological hallmark of granulomatous diseases . Although we did not observe granulomas after the 4-day exposure, FBGC might be an indication of their upcoming formation. Their formation has been induced by alternative activation of macrophages in vitro by stimulation of Th2 type cytokines Il-4 and Il-13 ,. Alternatively activated macrophages have been also associated with allergic airway inflammation .
Excessive mucus secretion in the airways and AHR are classical features of allergic airway inflammation . We found that pulmonary eosinophilia caused by rCNT was accompanied by increased goblet cell hyperplasia as well as elevation of AHR to inhaled metacholine. Moreover, the up-regulation of Th2 type cytokines Il-13 and Il-5, and down-regulation of Th1 type cytokine Ifn-γ in the lung tissue after rCNT inhalation supports the induction of allergic-like airway inflammation. Th2 type cytokines are typically found in the asthmatic airways  and the decreased level of Ifn-γ is to be expected since Th1 type cytokines are considered to be counter-regulatory to the Th2 type cytokines. Finally, eosinophil-chemoattractants were notably elevated, supporting the rCNT-induced pulmonary eosinophilia. To our knowledge, no previous studies exist describing an array of features characteristic to allergic airway inflammation and asthma after bare inhalation exposure to CNT, as seen in the present study. It should be also noted that full-blown allergic-like inflammation was elicited just in 5 days and without the conventional protein allergen or treatment with an artificial adjuvant substances (e.g. aluminum hydroxide). The current paradigm proposes that asthma is initiated by a sensitization phase, during which contact with (protein) allergens alerts the immune system, polarizes allergen-specific Th2 lymphocytes and induces secretion of allergen specific-IgE antibodies . In our experimental set up, the conventional sensitization phase cannot be developed due to the very short period of time and the lack of protein allergens, indicating that polarization of Th2 lymphocytes and generation of IgE antibodies is not possible. Thus, the rCNT-induced allergic-like inflammation is likely caused by the activation of the innate immune system, eliciting a novel type of allergic-like airway inflammation in the occupational health context.
The Reactive Airways Dysfunction Syndrome (RADS) is an occupational asthma-like syndrome that develops rapidly after a single exposure to high levels of irritating fume, smoke, vapor or aerosol . RADS differs from traditional asthma especially due to its acute nature with no latency period. Initial respiratory symptoms are followed by asthma-like symptoms and airway hyperresponsiveness. Irritant-induced asthma (IrIA) is also used to describe an asthmatic syndrome that results from a single or multiple high dose exposures to irritant products. Interestingly, both RADS and IrIA induce significant upper airway symptoms, nonspecific inflammation, neurogenic inflammation, primarily lymphocytic cellular infiltrate, macrophage activation, mast cell degranulation and epithelial desquamation -. The airway inflammation observed in the present study seems to be something in between the classic asthma and IrIA. Even though the inflammation lacks the sensitization phase and protein allergens, it still possesses classical features of allergic asthma such as Th2 cytokines, mucus production and pulmonary eosinophilia. Rather than allergens, the rCNT seem to act more like irritants in inducing a fast and dramatic innate immunity mediated Th2-type airway inflammation similar to allergic asthma.
Mast cells are known to be the central effectors in immediate hypersensitivity reactions . After encountering an allergen, IgE-sensitized mast cells release a broad panel of bioactive mediators and Th2 type cytokines (e.g. IL-4, IL-5, IL-13) in order to initiate and promote airway inflammation, and to strongly induce development of T cell responses ,,. Although traditional protein allergen-sensitization was not used in our experimental setting, we were interested in exploring whether the mast cells would also mediate the rCNT-driven inflammation. We found that the influx of eosinophils was increased and the expression of Il-13 was significantly decreased in the lungs of the mast cell deficient mice. However, the goblet cell activation was not dependent on these cells and the eosinophil attracting chemokines were likely derived from other sources. These findings suggest that mast cells modulate the rCNT-induced pulmonary inflammation partially.
Early events in the CNT-induced airway inflammation were examined by transcriptomics profiling. The analysis revealed that shortly after the 4 h exposure, the tissue of untreated and tCNT-exposed mice shared similar expression patterns, which were drastically distinct from rCNT-treated mice. Moreover, only rCNT induced increased expression of a number of inflammation-associated pathways. Since the transcriptomics data suggested that rCNT activate several innate immunity pathways, we wanted to estimate the role of alveolar macrophages and lung tissue cells in these early events. BAL cells were isolated immediately after and 24 h following the 4 h rCNT exposure and mRNA expression levels of BAL cells were compared to the mRNA levels of lung tissue of the same animals. Most of the pro-inflammatory Il-1β and Tnf-α expression was likely derived from the rCNT activated alveolar macrophages (i.e. BAL cells) as the tissue expression levels were much lower. On the other hand, the pro-allergic Il-33 , which promotes the activation of mast cells  and alternative activation of macrophages, was expressed by alveolar macrophages but also by other resident tissue cells. Similarly, the pro-allergic chemokine Ccl17 , whose overexpression has been observed earlier in lung macrophages of asthmatic patients , was highly up-regulated in BAL macrophages and lung tissue. Taken together, the present results demonstrate that rCNT activated alveolar macrophages are an important source of not only proinflammatory cytokines but also allergy promoting cytokines and chemokines. To our knowledge the transcriptomics analysis is a rather rarely used approach in similar studies and the early events in the CNT exposed mice appear weakly documented.
No significant induction of Il-13 and Il-4 was observed from the isolated BAL cells (data not shown) after a 4 h exposure to rCNT, suggesting that the alveolar macrophages are not synthetizing these Th2 cytokines at the early stages. Since mast cells are an important source of Th2 type cytokines,  we investigated their potential role as an early source of these cytokines. By using mast cell deficient mice we showed that the expression of Th2 type cytokines Il-13 and Il-4 is significantly decreased in the absence of mast cells suggesting that mast cells are likely an early source of these Th2 cytokines in rCNT induced inflammation. This is also supported by Katwa et al. that report MWCNT aspiration which actuates the extracellular release of Il-33 in lung tissue, leading to the activation of mast cells through the ST2 receptor and causing adverse pulmonary and cardiovascular responses. It has been previously reported that MWCNT induced Il-33 secretion from airway epithelia activating innate lymphoid cells and their release of Il-13 and Il-5 . In order to evaluate the possible role of innate lymphoid cells in the present study we measured innate lymphoid cell 2 (ILC2) markers Il-25 and ROR-α  in both BAL cells and lung tissue, but found no up-regulation in their expression in response to rCNT treatment (data not shown). Therefore, we suggest that the early events of MWCNT-induced responses include the activation of mast cells by Il-33 derived from macrophages or non-immune lung cells . However we cannot completely exclude the role of ILC2 as their functions and markers are to date not completely clear . It is of interest that carbon materials, in this case carboxy-fullerenes, can also act as inhibitors of allergic reactions by affecting the mast cell function .
In summary, we demonstrate that inhalation of rigid rod-shaped CNT induces all the signs of allergic airway inflammation. Experiments with mast cell deficient mice demonstrated that mast cells mediate the rCNT induced pulmonary eosinophilia and the expression of Il-13. Exploration of the early events by transcriptomics analysis reveals that a 4 h exposure to rCNT causes dramatic up-regulation of genes involved in innate immunity and cytokine/chemokine pathways, which also explains the pulmonary inflammation seen after one-week exposure. Early pro-inflammatory cytokines as well as pro-allergic cytokines and chemokines are synthetized by rCNT-activated alveolar macrophages, while mast cells are likely an early source of rCNT induced Il-4 and Il-13.
Our results indicate that in addition to the previously described asbestos associated pathologies, inhalation of rod-like CNT is able to induce a novel innate immunity mediated allergic-like airway inflammation-like reaction. They also highlight marked dissimilarities in the ability of different CNT to impact health. These observations should be taken into account in the risk assessment as well as in safety and protection measures when exposure to CNT is possible. However more knowledge on the long term effects, clinical impacts and dose–response relationships is still needed to draw solid conclusions on the risks of CNT.
CNT and their characterization
Assessment of bacterial lipopolysaccharide content
Levels of biologically active endotoxin in MWCNT were measured using a kinetic chromogenic Limulus amebocyte lysate assay (Kinetic QCL, Lonza, Walkersville, MD, USA) according to the instructions provided by the manufacturer. Endotoxin levels of the material samples were <0,022 EU/mg.
Female C57BL/6, BALB/c and KitW-sh/HNihrJaeBsmJ mice (7–8 weeks old) were purchased from Scanbur AB (Sollentuna, Sweden) and quarantined for one week. Mice were housed in groups of four in stainless steel cages bedded with aspen chip and were provided with standard mouse chow diet (Altromin no. 1314 FORTI, Altromin Spezialfutter GmbH & Co., Germany) and tap water ad libitum when not in exposure chamber. The environment of the animal room was carefully controlled, with a 12-h dark/light cycle, temperature of 20–21°C, and relative humidity of 40–45%. The experiments were performed in agreement with the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (Strasbourg March 18, 1986, adopted in Finland May 31, 1990). The study was approved by the Animal Experiment Board and the State Provincial Office of Southern Finland.
MWCNT were aerosolized with a fluidized bed aerosol generator (FBAG; TSI Model 3400A ) for which the materials were used without any pre-treatment. In the generator, a chain transports CNT to the fluidizing bed where material agglomerates are mechanically broken by 200-μm bronze pellets and continuous air flow. To increase CNT feed to fluidizing bed, additional air flow was used. Since the density of CNT was very low, the material reservoir of the FBAG was not large enough to accommodate material for a whole 4-h exposure. Thus, the reservoir was filled after two hours from the beginning of each exposure. During the experiments, the pressure of the exposure chamber differed from the atmospheric pressure ±200 Pa. Pressure in the chamber was dependent on the experiment flow values and on the air intake, whether it was drawn from room trough HEPA filter or from the generator. Detailed scheme of the inhalation setup is provided in Additional file 9.
Mice were exposed to aerosolized rCNT or tCNT for 4 hours at a time once or on four consecutive days in a whole-body inhalation chamber. Aerosol mass concentrations used for individual experiments were within a range of 6.2-8.2 mg/m3 for rCNT and 17.5-18.5 mg/m3 for tCNT. There is still limited amount of information about the concentrations found on workplaces partly due to the challenge of measuring the amounts of airborne CNT. In studies by Erdely et al. and Dahm et al., levels of CNT were found ranging from non-detectable to 1094 μg/m3. During CNT synthesis in general, concentrations are most likely in order of micrograms/m3 or less, but it is likely that exposure concentrations to large CNT granulates may be high (e.g. milligrams/m3) during post-processing of CNT powders. During the experiments, untreated control mice were housed in the same room with CNT-exposed animals. All mice were sacrificed by isoflurane overdose either immediately or 24 h after the exposure(s).
Measurement of airway responsiveness
Airway responsiveness of BALB/c mice was measured on day 5 using a single chamber, whole-body plethysmograph system (Buxco, Troy, NY, USA) as described earlier . Lung reactivity parameters were expressed as enhanced pause values (Penh). After measurement of lung responsiveness, mice were sacrificed using an overdose of isoflurane and samples were collected for analyses.
The tracheas of mice were surgically exposed and cannulated with a blunt syringe for collecting the BAL. The lungs were lavaged with 800 μl of Dulbecco’s phosphate buffered saline (DPBS, Thermo Fisher Scientific Inc., Waltham, MA, USA) for 10 s. BAL sample was cytocentrifuged onto a slide, and the cells were stained with May Grünwald-Giemsa (MGG) stain. The remaining cell suspension was centrifuged, supernatant was removed and the cells were fixed in 1:1 ethanol-DPBS mixture. The thoraxes were then opened, and half of the left pulmonary lobe was removed, quick-frozen and stored at −70°C for RNA isolation. The rest of the lung tissue was formalin-fixed, embedded in paraffin, cut, affixed on slides, and stained with hematoxylin and eosin (H&E), PAS and picrosirius red (PSR) solutions.
BAL cell counts
MGG-stained BAL cells were counted from three high-power fields under light microscope (Leica DM 4000B; Leica, Wetzlar, Germany).
Recruitment of inflammatory cells into the lungs and morphological alterations of the tissue were assessed after H&E staining. Lung sections stained with PSR solution were used to evaluate formation of fibrosis but also distribution of CNT within lungs since black fibers were easily detectable on the light background (Figure 1e). The number of mucus-producing cells was determined after PAS-staining from three bronchi per mouse in control group and six bronchi per mouse in treatment groups by counting PAS+ cells from 200 μm of bronchus surface under light microscope.
mRNA expression of cytokines and chemokines in lungs tissue
Lung samples were placed into Lysing matrix D tubes (MP Biomedicals, Illkirch, France) containing 1 ml of TRIsure reagent (Bioline Reagents Ltd., London, UK) and homogenized in a FastPrep FP120 machine (BIO 101, Thermo Savant, Waltham, MA, USA). The RNA extraction was performed following instructions provided by Bioline Reagents. The quantity and purity of isolated RNA was determined by NanoDrop spectrophotometer (ND-1000, Thermo Fisher Scientific Inc., Wilmington, NC, USA). Complementary DNA (cDNA) was synthesized from 500 ng of total RNA in a 25 μl reaction using MultiScribe Reverse Transcriptase and random primers (The High-Capacity cDNA Archive Kit, Applied Biosystems, Foster City, CA, USA) according to the manufacturer’s protocol. The synthesis was performed in a 2720 Thermal Cycler (Applied Biosystems, Carlsbad, CA, USA) starting at 25°C for 10 minutes and continuing at 37°C for 120 minutes. Primers and probes (18S ribosomal RNA, Ccl2, Ccl7, Ccl11, Ccl17, Ccl24, Cxcl5, Ifn-γ, Il-1β, Il-5, Il-13, Il-33, Tnf-α) for real-time quantitative polymerase chain reaction (PCR) analysis were ordered as pre-developed assay reagents from Applied Biosystems. The PCR assays were performed in 96-well optical reaction plates with Relative Quantification 7500 Fast System (7500 Fast Real-Time PCR system, Applied Biosystems) by the manufacturer’s instructions. Amplifications were done in 11 μl reaction volume containing TaqMan universal PCR master mix and primers provided by Applied Biosystems and 1 μl of cDNA sample. Ribosomal 18S was used as an endogenous control.
The microarray data have been deposited in NCBI Gene Expression Omnibus (GEO) database  and are accessible through GEO Series accession number GSE50176 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50176). Total RNA samples isolated from lung tissue as described above were quantified by NanoDrop and the quality was verified by Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA). Independent pools of two RNA samples each (total of 600 ng) were labeled using T7 RNA polymerase amplification method (Low Input Quick Amp Labeling Kit, Agilent Technologies), according to the instructions of the manufacturer. cRNAs were then labeled with Cy3 and Cy5 dyes (Agilent Technologies) and hybridized to the Agilent 2-color 60-mer oligo arrays (Agilent SurePrint G3 Mouse GE 8x60K). The slides were washed and scanned with Agilent Microarray Scanner G2505C (Agilent Technologies) and the raw intensity values were obtained with the Feature Extraction software, version 18.104.22.168 (Agilent Technologies). Raw data was quality checked according to the Agilent standard procedures. The median foreground intensities were imported into the R software version 3.0.0 (http://cran.r-project.org)  and analyzed with the BioConductor package limma . Log2 transformation and quantile normalization was performed on the single channel data separately, similarly for instance to - and according to the suggestions by Smyth and Altman . Background correction was not carried out, as suggested by Zahurak et al. . Subsequently the batch effect derived from the labeling was removed using the ComBat method  implemented in the sva package ,. The values of the probes recognizing the same NCBI Entrez Gene Ids  were further averaged into the final expression matrix. Differentially expressed genes were identified by using linear models and empirical Bayes pairwise comparisons (post hoc adjusted P < 0.01 and linear FC > |1.5|) . The resulting gene sets after Benjamini and Hochberg post hoc correction  were considered to be significant and were further studied by the DAVID version 6.7 annotation tool  with the default parameters.
Statistical analysis of cell counts, mRNA levels and AHR
Graphs were constructed and data were analyzed using GraphPad Prism 5 Software (GraphPad Software Inc., San Diego, CA, USA). For all statistical analysis we first performed analysis of variance using one-way ANOVA and when the ANOVA was positive we performed post-testing. An unpaired t-test or Mann–Whitney U-test was used to compare the differences between the groups. A P-value of <0.05 was considered to be statistically significant.
The work was supported by grants from the Academy of Finland (139115), from the European Community’s Seventh Framework Programme (FP7) under grant agreement no 309329 (NANOSOLUTIONS), the Finnish Work Environment Fund (109137) and the Research Funds of the University of Helsinki. The authors also wish to thank S. Savukoski, P. Alander, S. Hirvikorpi, L. Pylkkänen, E. Vanhala, J. Kangasluoma and S. Tillander for their excellent technical assistance.
- Lloyd CM, Hessel EM: Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol 2010, 10: 838–848. 10.1038/nri2870View ArticlePubMedGoogle Scholar
- Galli SJ, Tsai M, Piliponsky AM: The development of allergic inflammation. Nature 2008, 454: 445–454. 10.1038/nature07204PubMed CentralView ArticlePubMedGoogle Scholar
- Reuter S, Stassen M, Taube C: Mast cells in allergic asthma and beyond. Yonsei Med J 2010, 51: 797–807. 10.3349/ymj.2010.51.6.797PubMed CentralView ArticlePubMedGoogle Scholar
- Fanta CH: Asthma. N Engl J Med 2009, 360: 1002–1014. 10.1056/NEJMra0804579View ArticlePubMedGoogle Scholar
- Holtzman MJ: Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest 2012, 122: 2741–2748. 10.1172/JCI60325PubMed CentralView ArticlePubMedGoogle Scholar
- Stieb DM, Szyszkowicz M, Rowe BH, Leech JA: Air pollution and emergency department visits for cardiac and respiratory conditions: a multi-city time-series analysis. Environ Health 2009, 8: 25. 10.1186/1476-069X-8-25PubMed CentralView ArticlePubMedGoogle Scholar
- Silverman RA, Ito K: Age-related association of fine particles and ozone with severe acute asthma in New York City. J Allergy Clin Immunol 2010, 125: 367–373. e365 10.1016/j.jaci.2009.10.061View ArticlePubMedGoogle Scholar
- De Volder MF, Tawfick SH, Baughman RH, Hart AJ: Carbon nanotubes: present and future commercial applications. Science 2013, 339: 535–539. 10.1126/science.1222453View ArticlePubMedGoogle Scholar
- Shulaker MM, Hills G, Patil N, Wei H, Chen HY, Wong HS, Mitra S: Carbon nanotube computer. Nature 2013, 501: 526–530. 10.1038/nature12502View ArticlePubMedGoogle Scholar
- Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, Macnee W, Donaldson K: Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008, 3: 423–428. 10.1038/nnano.2008.111View ArticlePubMedGoogle Scholar
- Nygaard UC, Hansen JS, Samuelsen M, Alberg T, Marioara CD, Lovik M: Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. Toxicol Sci 2009, 109: 113–123. 10.1093/toxsci/kfp057View ArticlePubMedGoogle Scholar
- Inoue K, Koike E, Yanagisawa R, Hirano S, Nishikawa M, Takano H: Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicol Appl Pharmacol 2009, 237: 306–316. 10.1016/j.taap.2009.04.003View ArticlePubMedGoogle Scholar
- Ryman-Rasmussen JP, Tewksbury EW, Moss OR, Cesta MF, Wong BA, Bonner JC: Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma. Am J Respir Cell Mol Biol 2009, 40: 349–358. 10.1165/rcmb.2008-0276OCPubMed CentralView ArticlePubMedGoogle Scholar
- Van Hove CL, Maes T, Cataldo DD, Gueders MM, Palmans E, Joos GF, Tournoy KG: Comparison of acute inflammatory and chronic structural asthma-like responses between C57BL/6 and BALB/c mice. Int Arch Allergy Immunol 2009, 149: 195–207. 10.1159/000199715View ArticlePubMedGoogle Scholar
- Ronzani C, Casset A, Pons F: Exposure to multi-walled carbon nanotubes results in aggravation of airway inflammation and remodeling and in increased production of epithelium-derived innate cytokines in a mouse model of asthma. Arch Toxicol 2014, 88: 489–499. 10.1007/s00204-013-1116-3View ArticlePubMedGoogle Scholar
- Nygaard UC, Samuelsen M, Marioara CD, Lovik M: Carbon nanofibers have IgE adjuvant capacity but are less potent than nanotubes in promoting allergic airway responses. Biomed Res Int 2013, 2013: 476010. 10.1155/2013/476010PubMed CentralView ArticlePubMedGoogle Scholar
- Fulkerson PC, Rothenberg ME: Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov 2013, 12: 117–129. 10.1038/nrd3838View ArticlePubMedGoogle Scholar
- Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000, 105: 651–663. 10.1067/mai.2000.105712View ArticlePubMedGoogle Scholar
- Park EJ, Cho WS, Jeong J, Yi J, Choi K, Park K: Pro-inflammatory and potential allergic responses resulting from B cell activation in mice treated with multi-walled carbon nanotubes by intratracheal instillation. Toxicology 2009, 259: 113–121. 10.1016/j.tox.2009.02.009View ArticlePubMedGoogle Scholar
- Morimoto Y, Hirohashi M, Ogami A, Oyabu T, Myojo T, Todoroki M, Yamamoto M, Hashiba M, Mizuguchi Y, Lee BW, Kuroda E, Shimada M, Wang WN, Yamamoto K, Fujita K, Endoh S, Uchida K, Kobayashi N, Mizuno K, Inada M, Tao H, Nakazato T, Nakanishi J, Tanaka I: Pulmonary toxicity of well-dispersed multi-wall carbon nanotubes following inhalation and intratracheal instillation. Nanotoxicology 2012,6(6):587–599. 10.3109/17435390.2011.594912View ArticlePubMedGoogle Scholar
- Beamer CA, Girtsman TA, Seaver BP, Finsaas KJ, Migliaccio CT, Perry VK, Rottman JB, Smith DE, Holian A: IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology 2013, 7: 1070–1081. 10.3109/17435390.2012.702230PubMed CentralView ArticlePubMedGoogle Scholar
- Wang X, Katwa P, Podila R, Chen P, Ke PC, Rao AM, Walters DM, Wingard CJ, Brown JM: Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6 mice. Part Fibre Toxicol 2011, 8: 24. 10.1186/1743-8977-8-24PubMed CentralView ArticlePubMedGoogle Scholar
- Ma-Hock L, Treumann S, Strauss V, Brill S, Luizi F, Mertler M, Wiench K, Gamer AO, van Ravenzwaay B, Landsiedel R: Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. Toxicol Sci 2009, 112: 468–481. 10.1093/toxsci/kfp146View ArticlePubMedGoogle Scholar
- Porter DW, Hubbs AF, Chen BT, McKinney W, Mercer RR, Wolfarth MG, Battelli L, Wu N, Sriram K, Leonard S, Andrew M, Willard P, Tsuruoka S, Endo M, Tsukada T, Munekane F, Frazer DG, Castranova V: Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology 2013, 7: 1179–1194. 10.3109/17435390.2012.719649View ArticlePubMedGoogle Scholar
- Mangum J, Turpin E, Antao-Menezes A, Cesta M, Bermudez E, Bonner J: Single-Walled Carbon Nanotube (SWCNT)-induced interstitial fibrosis in the lungs of rats is associated with increased levels of PDGF mRNA and the formation of unique intercellular carbon structures that bridge alveolar macrophages In Situ. Particle Fibre Toxicol 2006, 3: 15. 10.1186/1743-8977-3-15View ArticleGoogle Scholar
- Helming L, Gordon S: Molecular mediators of macrophage fusion. Trends Cell Biol 2009, 19: 514–522. 10.1016/j.tcb.2009.07.005View ArticlePubMedGoogle Scholar
- McNally AK, DeFife KM, Anderson JM: Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity. Am J Pathol 1996, 149: 975–985.PubMed CentralPubMedGoogle Scholar
- DeFife KM, Jenney CR, McNally AK, Colton E, Anderson JM: Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J Immunol 1997, 158: 3385–3390.PubMedGoogle Scholar
- Dasgupta P, Keegan AD: Contribution of alternatively activated macrophages to allergic lung inflammation: a tale of mice and men. J Innate Immun 2012, 4: 478–488. 10.1159/000336025View ArticlePubMedGoogle Scholar
- Brooks SM, Weiss MA, Bernstein IL: REactive airways dysfunction syndrome (rads). persistent asthma syndrome after high level irritant exposures. Chest J 1985, 88: 376–384. 10.1378/chest.88.3.376View ArticleGoogle Scholar
- Tarlo S: Irritant-induced asthma in the workplace. Curr Allergy Asthma Rep 2013, 14: 1–6.Google Scholar
- Shakeri MS, Dick FD, Ayres JG: Which agents cause reactive airways dysfunction syndrome (RADS)? A systematic review. Occup Med 2008, 58: 205–211. 10.1093/occmed/kqn013View ArticleGoogle Scholar
- Banks DE: Workplace irritant exposures: do they produce true occupational asthma? Curr Opin Allergy Clin Immunol 2001, 1: 163–168. 10.1097/01.all.0000011002.72912.c8View ArticlePubMedGoogle Scholar
- Varney VA, Evans J, Bansal AS: Successful treatment of reactive airways dysfunction syndrome by high-dose vitamin D. J Asthma Allergy 2011, 4: 87–91. 10.2147/JAA.S19107PubMed CentralView ArticlePubMedGoogle Scholar
- Galli SJ, Grimbaldeston M, Tsai M: Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008, 8: 478–486. 10.1038/nri2327PubMed CentralView ArticlePubMedGoogle Scholar
- Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M: Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005, 23: 749–786. 10.1146/annurev.immunol.21.120601.141025View ArticlePubMedGoogle Scholar
- Liew FY, Pitman NI, McInnes IB: Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010, 10: 103–110. 10.1038/nri2692View ArticlePubMedGoogle Scholar
- Nakae S, Morita H, Ohno T, Arae K, Matsumoto K, Saito H: Role of interleukin-33 in innate-type immune cells in allergy. Allergol Int 2013, 62: 13–20. 10.2332/allergolint.13-RAI-0538View ArticlePubMedGoogle Scholar
- Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, Imai T, Yoshie O, Irimura T, Mizutani H, Matsushima K: Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999, 104: 1097–1105. 10.1172/JCI7613PubMed CentralView ArticlePubMedGoogle Scholar
- Staples KJ, Hinks TS, Ward JA, Gunn V, Smith C, Djukanovic R: Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17. J Allergy Clin Immunol 2012, 130: 1404–1412. e1407 10.1016/j.jaci.2012.07.023PubMed CentralView ArticlePubMedGoogle Scholar
- Katwa P, Wang X, Urankar RN, Podila R, Hilderbrand SC, Fick RB, Rao AM, Ke PC, Wingard CJ, Brown JM: A carbon nanotube toxicity paradigm driven by mast cells and the IL-(3)(3)/ST(2) axis. Small 2012, 8: 2904–2912. 10.1002/smll.201200873PubMed CentralView ArticlePubMedGoogle Scholar
- Wong SH, Walker JA, Jolin HE, Drynan LF, Hams E, Camelo A, Barlow JL, Neill DR, Panova V, Koch U, Radtke F, Hardman CS, Hwang YY, Fallon PG, McKenzie AN: Transcription factor RORalpha is critical for nuocyte development. Nat Immunol 2012,13(3):229–236. 10.1038/ni.2208PubMed CentralView ArticlePubMedGoogle Scholar
- Licona-Limon P, Kim LK, Palm NW, Flavell RA: TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 2013, 14: 536–542. 10.1038/ni.2617View ArticlePubMedGoogle Scholar
- Ryan JJ, Bateman HR, Stover A, Gomez G, Norton SK, Zhao W, Schwartz LB, Lenk R, Kepley CL: Fullerene nanomaterials inhibit the allergic response. J Immunol 2007, 179: 665–672. 10.4049/jimmunol.179.1.665View ArticlePubMedGoogle Scholar
- Marple VA, Liu BY, Rubow KL: A dust generator for laboratory use. Am Ind Hyg Assoc J 1978,39(1):26–32. 10.1080/0002889778507709View ArticlePubMedGoogle Scholar
- Dahm MM, Evans DE, Schubauer-Berigan MK, Birch ME, Fernback JE: Occupational exposure assessment in carbon nanotube and nanofiber primary and secondary manufacturers. Ann Occup Hyg 2012, 56: 542–556.PubMed CentralPubMedGoogle Scholar
- Erdely A, Dahm M, Chen BT, Zeidler-Erdely PC, Fernback JE, Birch ME, Evans DE, Kashon ML, Deddens JA, Hulderman T, Bilgesu SA, Battelli L, Schwegler-Berry D, Leonard HD, McKinney W, Frazer DG, Antonini JM, Porter DW, Castranova V, Schubauer-Berigan MK: Carbon nanotube dosimetry: from workplace exposure assessment to inhalation toxicology. Part Fibre Toxicol 2013,10(1):53. 10.1186/1743-8977-10-53PubMed CentralView ArticlePubMedGoogle Scholar
- Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997, 156: 766–775. 10.1164/ajrccm.156.3.9606031View ArticlePubMedGoogle Scholar
- Edgar R, Domrachev M, Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30: 207–210. 10.1093/nar/30.1.207PubMed CentralView ArticlePubMedGoogle Scholar
- R Core Team: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria; 2012. ISBN 3-900051-07-0 URL: http://www.R-project.org/.
- Smyth GK: Limma: Linear models for microarray data. In 2005.Google Scholar
- Procaccini C, De Rosa V, Galgani M, Carbone F, Cassano S, Greco D, Qian K, Auvinen P, Cali G, Stallone G, Formisano L, La Cava A, Matarese G: Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. J Immunol 2012,189(6):2941–2953. 10.4049/jimmunol.1200935View ArticlePubMedGoogle Scholar
- Kilpinen L, Tigistu-Sahle F, Oja S, Greco D, Parmar A, Saavalainen P, Nikkila J, Korhonen M, Lehenkari P, Kakela R, Laitinen S: Aging bone marrow mesenchymal stromal cells have altered membrane glycerophospholipid composition and functionality. J Lipid Res 2013, 54: 622–635. 10.1194/jlr.M030650PubMed CentralView ArticlePubMedGoogle Scholar
- Palgi M, Greco D, Lindstrom R, Auvinen P, Heino TI: Gene expression analysis of Drosophilaa Manf mutants reveals perturbations in membrane traffic and major metabolic changes. BMC Genomics 2012, 13: 134. 10.1186/1471-2164-13-134PubMed CentralView ArticlePubMedGoogle Scholar
- Smyth GK, Altman NS: Separate-channel analysis of two-channel microarrays: recovering inter-spot information. BMC Bioinformatics 2013, 14: 165. 10.1186/1471-2105-14-165PubMed CentralView ArticlePubMedGoogle Scholar
- Zahurak M, Parmigiani G, Yu W, Scharpf RB, Berman D, Schaeffer E, Shabbeer S, Cope L: Pre-processing Agilent microarray data. BMC Bioinformatics 2007, 8: 142. 10.1186/1471-2105-8-142PubMed CentralView ArticlePubMedGoogle Scholar
- Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995, 57: 289–300.Google Scholar
- Johnson WE, Li C, Rabinovic A: Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8: 118–127. 10.1093/biostatistics/kxj037View ArticlePubMedGoogle Scholar
- Leek JT, Johnson E, Parker HS, Jaffe AE, Storey JD: Sva: Surrogate Variable Analysis. 2013.Google Scholar
- Database resources of the National Center for Biotechnology Information Nucleic Acids Res 2013, 41: D8-D20. 10.1093/nar/gks1189View ArticleGoogle Scholar
- Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004,3(1):Article 3.Google Scholar
- Huang DW, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009,4(1):44–57. 10.1038/nprot.2008.211View ArticleGoogle Scholar
- Gueders MM, Paulissen G, Crahay C, Quesada-Calvo F, Hacha J, Van Hove C, Tournoy K, Louis R, Foidart JM, Noel A, Cataldo DD: Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production. Inflamm Res 2009,58(12):845–854. 10.1007/s00011-009-0054-2View ArticlePubMedGoogle Scholar
- Watanabe H, Numata K, Ito T, Takagi K, Matsukawa A: Innate immune response in Th1- and Th2-dominant mouse strains. Shock 2004,22(5):460–466. 10.1097/01.shk.0000142249.08135.e9View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.